3.3(top 10%)
impact factor
3.5K(top 10%)
74.6K(top 5%)
93(top 5%)
3.4(top 10%)
extended IF
all documents
doc citations
126(top 10%)

Top Articles

1Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosisRadiation Oncology2011600
2Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerRadiation Oncology2012375
3The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studiesRadiation Oncology2018301
4Wound healing after radiation therapy: Review of the literatureRadiation Oncology2012295
5Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approachesRadiation Oncology2019285
6A review of substitute CT generation for MRI-only radiation therapyRadiation Oncology2017278
7MR-guidance in clinical reality: current treatment challenges and future perspectivesRadiation Oncology2019252
8Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceRadiation Oncology2013232
9Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL studyRadiation Oncology2009226
10Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrenceRadiation Oncology2014220
11Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them allRadiation Oncology2015220
12Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay - A comparative studyRadiation Oncology2012210
13Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomesRadiation Oncology2011200
14Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patientsRadiation Oncology2010183
15Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regionsRadiation Oncology2010180
16Accelerated Partial Breast Irradiation (APBI): A review of available techniquesRadiation Oncology2010172
17Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessmentRadiation Oncology2012172
18Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 yearsRadiation Oncology2013172
19Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeRadiation Oncology2010168
20Radiation-induced Akt activation modulates radioresistance in human glioblastoma cellsRadiation Oncology2009166
21High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinomaRadiation Oncology2013166
223D Variation in delineation of head and neck organs at riskRadiation Oncology2012163
23Dosimetric evaluation of Acuros XB Advanced Dose Calculation algorithm in heterogeneous mediaRadiation Oncology2011157
24Investigation of the usability of conebeam CT data sets for dose calculationRadiation Oncology2008156
25The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implicationsRadiation Oncology2006154
26Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumorsRadiation Oncology2007151
27Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysisRadiation Oncology2014144
28Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient RegistryRadiation Oncology2018142
29Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The NetherlandsRadiation Oncology2012138
30Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local controlRadiation Oncology2011137
31Radiotherapy and radiosurgery for benign skull base meningiomasRadiation Oncology2009134
32Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastasesRadiation Oncology2014133
33Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancerRadiation Oncology2012131
34MicroRNA expression after ionizing radiation in human endothelial cellsRadiation Oncology2010130
35Stereotactic radiosurgery (SRS) for brain metastases: a systematic reviewRadiation Oncology2014129
36A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer riskRadiation Oncology2007128
37Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatmentsRadiation Oncology2009128
38Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implicationsRadiation Oncology2010128
39Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boostRadiation Oncology2013127
40Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancerRadiation Oncology2012124
41Current state of the art of regional hyperthermia treatment planning: a reviewRadiation Oncology2015122
42Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year studyRadiation Oncology2014121
43[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planningRadiation Oncology2009120
44Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)Radiation Oncology2011120
45Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancerRadiation Oncology2010119
46Ablative radiation therapy for locally advanced pancreatic cancer: techniques and resultsRadiation Oncology2019118
47Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomiaRadiation Oncology2015117
48Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter techniqueRadiation Oncology2018117
49A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?Radiation Oncology2014115
50Counting colonies of clonogenic assays by using densitometric softwareRadiation Oncology2007114